New York, NY, January 11, 2009 --(PR.com
)-- BioCardia, a privately held biointerventional cardiology company, announced today that it will participate in the OneMedPlace Finance Forum in San Francisco, CA from January 13-14, 2009. Peter Altman, Ph.D and CEO of BioCardia, will present on Tuesday, January 13th at 11:15 a.m. Pacific Time, at the Sir Francis Drake Hotel at 450 Powell St. Information about the OneMedPlace Finance forum may be found at www.onemedplace.com.
BioCardia is a biotherapeutic platform and product company based on fully developed medical device technologies.
BioCardia is engaged in two core businesses:
Helix Biotherapeutic Delivery offers a catheter system for the local delivery of cells, gene, and protein therapeutics to the heart. Morph Access Innovations develops advanced catheter products for interventional medicine. For more information, visit www.biocardia.com or contact the company at (800) 624-1179.
About OneMedPlace: OneMedPlace is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine—emerging companies and technologies seeking capital, distribution, visibility and resources to help finance, build and grow, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.